GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (XBRU:MITRA) » Definitions » Institutional Ownership

Mithra Pharmaceuticals (XBRU:MITRA) Institutional Ownership : 0.71% (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mithra Pharmaceuticals's institutional ownership is 0.71%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mithra Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mithra Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.


Mithra Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Mithra Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Institutional Ownership Chart

Mithra Pharmaceuticals Historical Data

The historical data trend for Mithra Pharmaceuticals can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 1.01 1.01 0.86 0.85 0.71 0.71 0.71 0.71 0.71 0.71

Mithra Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Mithra Pharmaceuticals (XBRU:MITRA) Business Description

Traded in Other Exchanges
Address
Rue Saint-Georges 5, Liege, BEL, 4000
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (XBRU:MITRA) Headlines

No Headlines